Johnson & Johnson announced today it was discontinuing sales of its talc-based baby powder products in the United States and Canada amid a firestorm of lawsuits claiming its signature product contains asbestos. The announcement comes just weeks after US District Judge Freda Wolfson ruled to allow testimony from plaintiffs’ experts in the New Jersey-based Multidistrict Litigation. Thousands of claimants have argued that regular exposure to the baby powder has caused them to develop ovarian cancer and mesothelioma.
Was Decision To Pull Talcum Powder Related To 2019 Recall?
In October 2019, J&J issued its first ever recall of talc-based baby powder after FDA testing found trace amounts of asbestos in the product. The company claims its decision to now cease sales has nothing to do with the safety of the product and cited lawsuits as the reason for a decline in consumer demand. The pharmaceutical giant will continue to sell its cornstarch-based powder.
Ruling Clears Plaintiffs For Bellwether Trials
Judge Wolfson’s ruling allows plaintiffs to argue that J&J’s Talc-based baby powder contains asbestos and can contribute to the development of ovarian cancer. The decision opens the path for bellwether trials to begin in the MDL sometime in 2021.
Let Us Help
GoldenbergLaw is currently litigating cases where individuals have been diagnosed with ovarian cancer or mesothelioma after long term talcum powder exposure. To get in touch with us regarding any potential talcum powder cases we may investigate on your behalf, please contact our Senior Partner Stuart Goldenberg at firstname.lastname@example.org or by phone at 612-335-9960, or our Partner Noah Lauricella at email@example.com or by phone at 612-335-9977.
Contact us today, and let us deliver the Gold standard advocacy you deserve.